Scott C Woller Selected Research

Scott C Woller Research Topics

Disease

22	Venous Thromboembolism 03/2024 - 01/2008
17	Hemorrhage 05/2023 - 01/2008
13	Venous Thrombosis (Deep-Vein Thrombosis) 12/2023 - 11/2005
11	Pulmonary Embolism 10/2022 - 01/2008
10	Atrial Fibrillation 12/2022 - 10/2014
9	Stroke (Strokes) 12/2022 - 10/2014
9	Thrombosis (Thrombus) 01/2022 - 01/2016
8	Dementia (Dementias) 12/2022 - 12/2014
7	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2023 - 04/2016
5	COVID-19 05/2023 - 01/2022
5	Neoplasms (Cancer) 01/2020 - 10/2011
3	Obesity 05/2023 - 04/2016
3	Thrombophilia 10/2020 - 01/2016
3	Critical Illness (Critically Ill) 12/2018 - 09/2015
3	Thromboembolism 06/2017 - 07/2016
2	Hypoxia (Hypoxemia) 01/2023 - 01/2018
2	Cognitive Dysfunction 12/2022 - 05/2019
2	Infections 01/2022 - 01/2020
2	Postthrombotic Syndrome 12/2021 - 12/2021
2	Fatigue 07/2018 - 10/2016
2	Thrombocytopenia (Thrombopenia) 07/2018 - 10/2016
2	Wounds and Injuries (Trauma) 04/2018 - 04/2016
2	Hypotension (Low Blood Pressure) 01/2018 - 02/2016
2	Transient Ischemic Attack 07/2016 - 12/2014
1	Brain Injuries (Brain Injury) 05/2019
1	Inflammation (Inflammations) 02/2018
1	Renal Insufficiency (Renal Failure) 01/2018
1	Hypertension (High Blood Pressure) 06/2017
1	Heart Failure 06/2017
1	Alzheimer Disease (Alzheimer's Disease) 11/2016
1	Myocardial Infarction 08/2016
1	Vascular Diseases (Vascular Disease) 11/2015
1	Kidney Neoplasms (Kidney Cancer) 09/2015
1	Upper Extremity Deep Vein Thrombosis 09/2015
1	Acute Coronary Syndrome 01/2015
1	Embolism (Embolus) 10/2014
1	Secondary Hyperparathyroidism 06/2010
1	Calciphylaxis 06/2010
1	Ulcer 06/2010
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2010

Drug/Important Bio-Agent (IBA)

18	AnticoagulantsIBA 12/2023 - 02/2010
18	Warfarin (Coumadin)FDA LinkGeneric 05/2023 - 06/2010
8	fibrin fragment D (D-dimer)IBA 08/2022 - 11/2005
7	apixabanIBA 12/2023 - 02/2016
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2019
4	RivaroxabanIBA 12/2023 - 10/2014
4	Dabigatran FDA Link 12/2022 - 10/2014
3	Vitamin K FDA Link 04/2016 - 10/2014
2	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 10/2022 - 01/2018
2	Heparin (Liquaemin)FDA LinkGeneric 07/2018 - 10/2016
2	Enoxaparin (Lovenox)FDA LinkGeneric 04/2018 - 06/2010
2	cupric sulfide (CuS)IBA 01/2018 - 02/2010
2	idraparinuxIBA 01/2008 - 01/2008
1	Oxygen (Dioxygen)IBA 01/2023
1	Antiphospholipid AntibodiesIBA 10/2020
1	A-factor (Streptomyces)IBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2018
1	Atorvastatin (Lipitor)FDA Link 02/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017
1	Clopidogrel (Plavix)FDA Link 01/2017
1	omega-Chloroacetophenone (Mace)IBA 08/2016
1	AntibodiesIBA 04/2016
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2016
1	edoxabanIBA 02/2016
1	Estrogens (Estrogen)FDA Link 01/2016
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2015
1	Irritants (Vesicants)IBA 09/2015
1	Factor Xa (Coagulation Factor Xa)IBA 10/2014
1	CalciumIBA 06/2010

Therapy/Procedure

18	Therapeutics 03/2024 - 01/2008
4	Catheters 12/2023 - 09/2015
4	Secondary Prevention 12/2021 - 04/2016
4	Central Venous Catheters 01/2020 - 09/2015
4	Chemoprevention 07/2018 - 04/2016
3	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2022 - 01/2017
2	Contraindications 07/2018 - 01/2018
1	Drug Tapering 12/2023
1	Stents 12/2023
1	Liver Transplantation 03/2023
1	Length of Stay 01/2021
1	Arthroplasty 01/2019
1	Catheter Ablation 01/2019
1	Vascular Access Devices (Arterial Line) 12/2018
1	Orthopedic Procedures 02/2018
1	Artificial Respiration (Mechanical Ventilation) 04/2016
1	Thrombolytic Therapy 02/2016
1	Bed Rest (Bedrest) 10/2011
1	Hyperbaric Oxygenation 06/2010
1	Drug Substitution 06/2010